Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists
- 7 February 1992
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 571 (2), 199-203
- https://doi.org/10.1016/0006-8993(92)90655-s
Abstract
To investigate the possible mechanisms of the alterations in morphine-induced analgesia observed in diabetic mice, we examined the influence of streptozotocin-induced (STZ-induced) diabetes on analgesia mediated by the different opioid receptors. The antinociceptive potency of morphine (10 mg/kg), administered s.c., as determined by both the tail-pinch and the tail-flick test, was significantly reduced in diabetic mice as compared to that in controls. Mice with STZ-induced diabetes had significantly decreased sensitivity to intracerebroventricularly (i.c.v.) administered μ-opioid agonists, such as morphine (10 μg) and [d-Ala2, N-Me Phe4,Gly-ol5]enkephalin (DAMGO, 0.5 μg). However, i.c.v. administration of [d-Pen2,5]enkephalin (DPDPE, 5 μg), a δ-opioid agonist, and U-50,488H (50 μg), a κ-opioid agonist, produced pronounced antinociception in both control and diabetic mice. Furthermore, there were no significant differences in antinociceptive potency between diabetic and control mice when morphine (1 μg), DAMGO (10 μg), DPDPE (0.5 μg) or U-50,488H (50 μg) was administered intrathecally. In conclusion, mice with STZ-induced diabetes are selectively hyporesponsive to supraspinal μ-opioid receptor-mediated antinociception, but they are normally responsive to activation of δ- and κ-opioid receptors.Keywords
This publication has 16 references indexed in Scilit:
- Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuliPharmacology Biochemistry and Behavior, 1991
- Development of supersensitivity to substance P in the spinal cord of the streptozotocin-induced diabetic ratsPharmacology Biochemistry and Behavior, 1990
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988
- The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermatesLife Sciences, 1988
- C57BL/6J-bgJ (beige) mice: Differential sensitivity in the tail flick test to centrally administered MU- and delta-opioid receptor agonistsLife Sciences, 1987
- Multiple opiate binding sites in rat spinal cordLife Sciences, 1982
- Multiple opiate receptor sites on primary afferent fibresNature, 1980
- Differential Regulation by Guanine Nucleotides of Opiate Agonist and Antagonist Receptor InteractionsJournal of Neurochemistry, 1980
- Reduced sensitivity to L-tryptophan and p-chloro amphetamine in streptozotocin-diabetic ratsJournal of Pharmacy and Pharmacology, 1978
- Identification of novel high affinity opiate receptor binding in rat brainNature, 1975